Trials / Completed
CompletedNCT02209077
Spectralis OCT Repeatability and Reproducibility Study
Repeatability and Reproducibility of Optic Nerve Head (ONH), Retinal Nerve Fiber Layer (RNFL), and Macula Parameters With the Heidelberg Spectralis OCT.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Heidelberg Engineering GmbH · Industry
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
This single-center, prospective, interventional clinical study is conducted to evaluate the repeatability and reproducibility of structural parameters of the optic nerve head, the peripapillary retinal nerve fiber layer, and the macula using the Heidelberg Spectralis OCT (Optical Coherence Tomography) device. Data obtained from healthy volunteers in this study are compared to those from a previous, larger healthy volunteer study that was conducted in the United States and Europe (S-2012-1), and data from glaucoma patients are compared to those from the healthy volunteers.
Detailed description
The study will include approximately 15 normal subjects and approximately 15 subjects who have glaucoma of varying degree. All subjects will undergo Spectralis OCT imaging and other study procedures in one single visit. All examinations performed on the subjects are non-significant risk procedures because the medical devices are cleared for marketing in Europe and in the U.S. Total study duration is anticipated to not exceed 4 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | OCT performed to collect data from the back of the eye | comparative retinal parameters with Spectralis OCT |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2013-07-01
- Completion
- 2013-07-01
- First posted
- 2014-08-05
- Last updated
- 2014-08-05
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02209077. Inclusion in this directory is not an endorsement.